Deferiere Raphael
Insider CIK 2071320 · CNTA Chief Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 165,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 42,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer | 2026-06-24 | 2026-06-24 | 11,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2026-02-02 | 2026-02-03 | 42,000 | — | $0 | 42,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2026-02-02 | 2026-02-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2025-06-02 | 2025-06-03 | 165,000 | — | $0 | 165,000 | SEC↗ |